Prospective Observation Cohort Study of Malignant Lymphoma Patients
Although the cure rate of lymphoma has been increased due to the development of newer
effective drugs, a substantial portion of patients is still suffered from relapse.
Furthermore, the treatment-related morbidity is another factor which can make the treatment
outcome worse in patients with lymphoma, especially elderly patients. Thus, this study is
going to assess factors which may affect the treatment outcome and the risk of
treatment-related morbidity.
1.Biologic factors associated with the aggressiveness of lymphoma
- molecular markers in serum, cytogenetic markers 2.Factors associated with the risk of
treatment-related morbidity
- comorbidity, nutrition status, performance status, quality of life at diagnosis
Observational [Patient Registry]
Observational Model: Cohort, Time Perspective: Prospective
All cause mortality
Disease and non-disease-related mortality including treatment-related death
5 years
Yes
Korea: Food and Drug Administration
2011-11-056
NCT01877109
January 2012
December 2014
Name | Location |
---|